Edgewise Therapeutics Inc (EWTX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: EWTX Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-05-03 2024-05-02 S Sale

Carruthers R Michael

Chief Financial Officer

Officer
2,157 -5.8%
18.91
40,789 USD 		2,157 -5.8% 18.91 40,789 USD
2024-05-03 2024-05-02 S Sale

Donovan Joanne M.

CMO

Officer
3,682 -15.6%
18.91
69,627 USD 		3,682 -15.6% 18.91 69,627 USD
2024-05-03 2024-05-02 S Sale

MOORE JOHN R

General Counsel

Officer
1,956 -37.6%
18.91
36,988 USD 		1,956 -37.6% 18.91 36,988 USD
2024-05-03 2024-05-02 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
1,576 -17.9%
18.91
29,802 USD 		1,576 -17.9% 18.91 29,802 USD
2024-05-03 2024-05-02 S Sale

KOCH KEVIN

President and CEO

Executive Director
3,152 -17.9%
18.91
59,604 USD 		3,152 -17.9% 18.91 59,604 USD
2024-05-03 2024-05-02 S Sale

Derakhshan Behrad

Chief Business Officer

Officer
1,718 -11.3%
18.91
32,487 USD 		1,718 -11.3% 18.91 32,487 USD
2024-02-09 2024-02-09 S Sale

Derakhshan Behrad

Chief Business Officer

Officer
4,800 -40.6%
20.04
96,209 USD 		4,800 -40.6% 20.04 96,209 USD
2024-02-09 2024-02-09 S Sale

MOORE JOHN R

General Counsel

Officer
8,029 -100.0%
20.01
160,657 USD 		8,029 -100.0% 20.01 160,657 USD
2024-02-09 2024-02-08 S Sale

Derakhshan Behrad

Chief Business Officer

Officer
4,600 -39.6%
20.01
92,049 USD 		4,600 -39.6% 20.01 92,049 USD
2024-02-09 2024-02-08 S Sale

MOORE JOHN R

General Counsel

Officer
3,813 -100.0%
20.01
76,285 USD 		3,813 -100.0% 20.01 76,285 USD
2024-02-09 2024-02-07 S Sale

Derakhshan Behrad

Chief Business Officer

Officer
600 -7.9%
20.00
12,000 USD 		600 -7.9% 20.00 12,000 USD
2024-02-09 2024-02-07 S Sale

MOORE JOHN R

General Counsel

Officer
17,993 -100.0%
20.00
359,864 USD 		17,993 -100.0% 20.00 359,864 USD
2024-01-25 2024-01-23 B Purchase

Thompson Peter A.

Non-Executive Director Large shareholder
454,545 +3.3%
11.00
4,999,995 USD 		454,545 +3.3% 11.00 4,999,995 USD
2024-01-25 2024-01-23 B Purchase

ORBIMED ADVISORS LLC

Non-Executive Director Large shareholder
454,545 +3.3%
11.00
4,999,995 USD 		454,545 +3.3% 11.00 4,999,995 USD
2024-01-25 2024-01-23 S Sale

Carruthers R Michael

Chief Financial Officer

Officer
90,000 -75.6%
15.78
1,419,759 USD 		90,000 -75.6% 15.78 1,419,759 USD
2023-12-28 2023-12-27 PS Planned sale

MOORE JOHN R

General Counsel

Officer
8,497 -100.0%
10.50
89,219 USD 		8,497 -100.0% 10.50 89,219 USD
2023-12-28 2023-12-26 B Purchase

Fox Jonathan C

Non-Executive Director
10,857 +inf%
9.30
100,958 USD 		10,857 +inf% 9.30 100,958 USD
2023-12-28 2023-12-26 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
172,585 -98.0%
9.33
1,610,097 USD 		172,585 -98.0% 9.33 1,610,097 USD
2023-05-03 2023-05-02 S Sale

Donovan Joanne M.

CMO

Officer
3,254 -24.6%
8.90
28,977 USD 		3,254 -24.6% 8.90 28,977 USD
2023-05-03 2023-05-02 S Sale

MOORE JOHN R

General Counsel

Officer
1,897 -22.4%
8.90
16,893 USD 		1,897 -22.4% 8.90 16,893 USD
2023-05-03 2023-05-02 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
1,602 -0.9%
8.90
14,266 USD 		1,602 -0.9% 8.90 14,266 USD
2023-05-03 2023-05-02 S Sale

Carruthers R Michael

Chief Financial Officer

Officer
1,336 -7.7%
8.90
11,897 USD 		1,336 -7.7% 8.90 11,897 USD
2023-05-03 2023-05-02 S Sale

Derakhshan Behrad

Chief Business Officer

Officer
1,747 -19.9%
8.90
15,557 USD 		1,747 -19.9% 8.90 15,557 USD
2023-05-03 2023-05-02 S Sale

KOCH KEVIN

President and CEO

Executive Director
3,203 -30.8%
8.90
28,522 USD 		3,203 -30.8% 8.90 28,522 USD
2022-10-05 2022-10-03 PS Planned sale

MOORE JOHN R

General Counsel

Officer
4,730 -61.2%
9.76
46,155 USD 		4,730 -61.2% 9.76 46,155 USD
2022-09-16 2022-09-16 B Purchase

Thompson Peter A.

Non-Executive Director Large shareholder
484,496 +3.6%
10.32
4,999,999 USD 		484,496 +3.6% 10.32 4,999,999 USD
2022-09-16 2022-09-16 B Purchase

ORBIMED ADVISORS LLC

Non-Executive Director Large shareholder
484,496 +3.6%
10.32
4,999,999 USD 		484,496 +3.6% 10.32 4,999,999 USD
2022-09-16 2022-09-14 B Purchase

Novo Holdings A/S

Large shareholder
484,496 +8.7%
10.32
4,999,999 USD 		484,496 +8.7% 10.32 4,999,999 USD
2022-09-08 2022-09-06 PS Planned sale

MOORE JOHN R

General Counsel

Officer
2,351 -43.9%
10.99
25,842 USD 		2,351 -43.9% 10.99 25,842 USD
2022-09-08 2022-09-06 PS Planned sale

MOORE JOHN R

General Counsel

Officer
2,379 -30.8%
10.83
25,756 USD 		2,379 -30.8% 10.83 25,756 USD
2022-08-05 2022-08-03 S Sale

MOORE JOHN R

General Counsel

Officer
9,232 -75.5%
9.31
85,921 USD 		9,232 -75.5% 9.31 85,921 USD
2022-07-07 2022-07-06 S Sale

MOORE JOHN R

General Counsel

Officer
1,046 -25.9%
8.54
8,928 USD 		1,046 -25.9% 8.54 8,928 USD
2022-07-07 2022-07-05 S Sale

MOORE JOHN R

General Counsel

Officer
8,186 -73.2%
8.35
68,329 USD 		8,186 -73.2% 8.35 68,329 USD
2022-06-21 2022-06-21 S Sale

MOORE JOHN R

General Counsel

Officer
31,078 -91.2%
7.29
226,695 USD 		31,078 -91.2% 7.29 226,695 USD
2022-06-21 2022-06-17 S Sale

MOORE JOHN R

General Counsel

Officer
22,127 -88.1%
6.62
146,434 USD 		22,127 -88.1% 6.62 146,434 USD
2022-06-21 2022-06-16 S Sale

MOORE JOHN R

General Counsel

Officer
14,722 -83.1%
6.17
90,805 USD 		14,722 -83.1% 6.17 90,805 USD
2022-06-15 2022-06-15 S Sale

MOORE JOHN R

General Counsel

Officer
18,075 -85.8%
6.11
110,445 USD 		18,075 -85.8% 6.11 110,445 USD
2022-06-15 2022-06-15 S Sale

MOORE JOHN R

General Counsel

Officer
585 -2.7%
6.11
3,575 USD 		585 -2.7% 6.11 3,575 USD
2022-06-15 2022-06-14 S Sale

MOORE JOHN R

General Counsel

Officer
3,628 -54.7%
6.02
21,855 USD 		3,628 -54.7% 6.02 21,855 USD
2022-06-15 2022-06-13 S Sale

MOORE JOHN R

General Counsel

Officer
4,093 -57.7%
6.01
24,582 USD 		4,093 -57.7% 6.01 24,582 USD
2022-06-10 2022-06-10 S Sale

MOORE JOHN R

General Counsel

Officer
7,125 -70.4%
6.05
43,120 USD 		7,125 -70.4% 6.05 43,120 USD
2022-06-10 2022-06-09 S Sale

MOORE JOHN R

General Counsel

Officer
7,615 -71.7%
6.49
49,397 USD 		7,615 -71.7% 6.49 49,397 USD
2022-06-10 2022-06-08 S Sale

MOORE JOHN R

General Counsel

Officer
12,566 -80.7%
6.63
83,362 USD 		12,566 -80.7% 6.63 83,362 USD
2022-06-07 2022-06-07 S Sale

MOORE JOHN R

General Counsel

Officer
17,150 -85.1%
6.61
113,276 USD 		17,150 -85.1% 6.61 113,276 USD
2022-06-07 2022-06-07 S Sale

MOORE JOHN R

General Counsel

Officer
973 -24.5%
6.61
6,427 USD 		973 -24.5% 6.61 6,427 USD
2022-06-07 2022-06-06 S Sale

MOORE JOHN R

General Counsel

Officer
13,934 -82.3%
6.03
84,085 USD 		13,934 -82.3% 6.03 84,085 USD
2022-06-07 2022-06-03 S Sale

MOORE JOHN R

General Counsel

Officer
15,230 -83.5%
6.05
92,198 USD 		15,230 -83.5% 6.05 92,198 USD
2022-05-20 2022-05-18 B Purchase

Thompson Peter A.

Non-Executive Director Large shareholder
138,000 +1.0%
7.21
994,980 USD 		138,000 +1.0% 7.21 994,980 USD
2022-05-20 2022-05-18 B Purchase

ORBIMED ADVISORS LLC

Non-Executive Director Large shareholder
138,000 +1.0%
7.21
994,980 USD 		138,000 +1.0% 7.21 994,980 USD
2022-05-18 2022-05-16 PS Planned sale

MOORE JOHN R

General Counsel

Officer
10,800 -78.3%
7.42
80,146 USD 		10,800 -78.3% 7.42 80,146 USD
2021-11-17 2021-11-15 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
38 -100.0%
19.61
745 USD 		38 -100.0% 19.61 745 USD
2021-11-17 2021-11-15 PS Planned sale

Russell Alan J

Chief Scientific Officer

Executive Director
441 -92.1%
19.07
8,410 USD 		441 -92.1% 19.07 8,410 USD
2021-11-12 2021-11-12 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
8,562 -94.7%
19.51
167,074 USD 		8,562 -94.7% 19.51 167,074 USD
2021-11-12 2021-11-11 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
3,681 -28.9%
20.43
75,195 USD 		3,681 -28.9% 20.43 75,195 USD
2021-11-12 2021-11-11 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
15,595 -55.1%
19.82
309,043 USD 		15,595 -55.1% 19.82 309,043 USD
2021-11-12 2021-11-10 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
580 -2.0%
20.21
11,723 USD 		580 -2.0% 20.21 11,723 USD
2021-11-12 2021-11-10 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
11,746 -28.9%
19.70
231,447 USD 		11,746 -28.9% 19.70 231,447 USD
2021-11-12 2021-11-09 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
12,712 -23.8%
20.30
258,031 USD 		12,712 -23.8% 20.30 258,031 USD
2021-11-12 2021-11-09 PS Planned sale

Russell Alan J

Chief Scientific Officer

Executive Director
16,864 -24.0%
19.94
336,275 USD 		16,864 -24.0% 19.94 336,275 USD
2021-11-08 2021-11-08 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
9,017 -11.4%
20.16
181,824 USD 		9,017 -11.4% 20.16 181,824 USD
2021-11-08 2021-11-05 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
13,036 -14.1%
19.62
255,783 USD 		13,036 -14.1% 19.62 255,783 USD
2021-11-08 2021-11-05 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
6 -0.0%
20.70
124 USD 		6 -0.0% 20.70 124 USD
2021-11-08 2021-11-04 PS Planned sale

Russell Alan J

Chief Scientific Officer

Executive Director
7,392 -7.4%
19.76
146,092 USD 		7,392 -7.4% 19.76 146,092 USD
2021-11-03 2021-11-03 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
1,119 -1.1%
19.42
21,726 USD 		1,119 -1.1% 19.42 21,726 USD
2021-11-03 2021-11-03 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
4,243 -4.0%
18.84
79,944 USD 		4,243 -4.0% 18.84 79,944 USD
2021-11-03 2021-11-03 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
20,822 -16.5%
17.98
374,425 USD 		20,822 -16.5% 17.98 374,425 USD
2021-11-03 2021-11-02 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
17,519 -12.2%
17.43
305,360 USD 		17,519 -12.2% 17.43 305,360 USD
2021-11-03 2021-11-01 PS Planned sale

Russell Alan J

Chief Scientific Officer

Executive Director
469 -0.3%
18.02
8,454 USD 		469 -0.3% 18.02 8,454 USD
2021-10-18 2021-10-15 PS Planned sale

Russell Alan J

Chief Scientific Officer

Executive Director
126 -0.1%
18.00
2,268 USD 		126 -0.1% 18.00 2,268 USD
2021-10-18 2021-10-15 PS Planned sale

Russell Alan J

Chief Scientific Officer

Executive Director
1,307 -0.9%
18.13
23,698 USD 		1,307 -0.9% 18.13 23,698 USD
2021-10-18 2021-10-14 PS Planned sale

Russell Alan J

Chief Scientific Officer

Executive Director
5,749 -3.8%
18.18
104,517 USD 		5,749 -3.8% 18.18 104,517 USD
2021-10-13 2021-10-11 PS Planned sale

Russell Alan J

Chief Scientific Officer

Executive Director
1,270 -0.8%
18.02
22,885 USD 		1,270 -0.8% 18.02 22,885 USD
2021-10-08 2021-10-08 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
5,902 -3.7%
18.15
107,121 USD 		5,902 -3.7% 18.15 107,121 USD
2021-10-08 2021-10-07 S Sale

Russell Alan J

Chief Scientific Officer

Executive Director
13,018 -7.6%
18.56
241,614 USD 		13,018 -7.6% 18.56 241,614 USD
2021-10-08 2021-10-06 PS Planned sale

Russell Alan J

Chief Scientific Officer

Executive Director
2,108 -1.2%
18.03
38,007 USD 		2,108 -1.2% 18.03 38,007 USD